Efficacy of 21 human placenta extracts to be clarified

The Korea Food and Drug Administration plans to review controversial efficacy and exaggerated advertisements of human placenta products within this year, based on clinical data and on-spot hospital inspections.

“We will modify or cancel the license of already approved placenta products unless there is evidence supporting placenta as a health treatment,” a KFDA official said.

Placental ext...